Related Experiment Video

Updated: Jun 7, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

PUMA is a novel target of miR-221/222 in human epithelial cancers

Chunzhi Zhang1, Junxia Zhang, Anlin Zhang

  • 1Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology, Tianjin Neurological Institute, Tianjin, PR China.

International Journal of Oncology
|November 3, 2010
PubMed

Insights

MicroRNAs miR-221/222 promote cancer by inhibiting apoptosis. Targeting these microRNAs and their target, PUMA, may offer new cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • MicroRNAs miR-221 and miR-222 are often elevated in human epithelial cancers.
  • The precise role of miR-221/222 in cancer development remains unclear.
  • Understanding miR-221/222 mechanisms is crucial for targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of miR-221/222 in epithelial cancer progression.
  • To identify the molecular targets of miR-221/222 involved in carcinogenesis.
  • To explore the therapeutic potential of modulating miR-221/222 in cancer.

Main Methods:

  • Utilized bioinformatics to predict miR-221/222 targets.
  • Performed luciferase reporter assays to validate direct targeting.
  • Assessed the impact of miR-221/222 inhibition on cancer cell proliferation and apoptosis.
  • Examined expression levels of PUMA in epithelial cancer cells.

Main Results:

  • Reduced miR-221/222 levels inhibited proliferation and induced apoptosis in A549 lung and MCF-7 breast cancer cells.
  • miR-221/222 were found to directly target the 3' untranslated region (3'UTR) of PUMA (p53 upregulated modulator of apoptosis).
  • miR-221/222 co-modulate PUMA expression, acting as endogenous regulators of apoptosis.

Conclusions:

  • PUMA is a direct downstream target of miR-221/222 in epithelial cancers.
  • miR-221/222 play a significant role in regulating apoptosis and cell proliferation.
  • Targeting miR-221/222 and PUMA presents a potential therapeutic strategy for epithelial cancers.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...